@Article{Szechiński2008,
journal="Reumatologia/Rheumatology",
issn="0034-6233",
volume="46",
number="3",
year="2008",
title="REVIEW PAPERAdalimumab \– the first fully human monoclonal antibody used in the treatment  of rheumatoid arthritis",
abstract="Rheumatoid arthritis is a systemic inflammatory disease leading to joint deformation and multiorgan dysfunction. Adalimumab belongs to a new class of antirheumatic drugs. This article gives a systematic review of data supporting the efficacy of adalimumab in the treatment of rheumatoid arthritis.",
author="Szechiński, Jacek
and Jeka, Sławomir
and Borysewicz, Krzysztof
and Filipowicz-Sosnowska, Anna
and Kolossa, Katarzyna
and Kucharz, Eugeniusz
and Nowak, Beata
and Świerkot, Jerzy
and Wiland, Piotr",
pages="151--158",
url="https://www.termedia.pl/REVIEW-PAPER-Adalimumab-8211-the-first-fully-human-monoclonal-antibody-used-in-the-treatment-of-rheumatoid-arthritis,18,10757,1,1.html"
}